BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 121 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 3.70 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,947,600 | +0.6% | 1,970,000 | 0.0% | 0.25% | +7.3% |
| Q2 2023 | $13,868,800 | +50.8% | 1,970,000 | +78.6% | 0.23% | +38.5% |
| Q1 2023 | $9,198,094 | +8.9% | 1,102,889 | +5.3% | 0.17% | -54.8% |
| Q4 2018 | $8,449,000 | +5.8% | 1,047,000 | 0.0% | 0.37% | +27.6% |
| Q3 2018 | $7,989,000 | +461.0% | 1,047,000 | +261.0% | 0.29% | +295.9% |
| Q4 2017 | $1,424,000 | -6.3% | 290,000 | 0.0% | 0.07% | -14.0% |
| Q3 2017 | $1,520,000 | -5.7% | 290,000 | 0.0% | 0.09% | -14.0% |
| Q2 2017 | $1,612,000 | – | 290,000 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Burrage Capital Management LLC | 1,105,673 | $8,237,000 | 6.28% |
| Sarissa Capital Management LP | 8,175,000 | $60,903,000 | 6.22% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,980,870 | $22,207,000 | 2.78% |
| DG Capital Management, LLC | 1,075,732 | $8,014,000 | 1.70% |
| Ghost Tree Capital, LLC | 900,000 | $6,705,000 | 1.49% |
| Parkman Healthcare Partners LLC | 538,370 | $4,011,000 | 1.03% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,835,810 | $43,477,000 | 0.86% |
| Formidable Asset Management, LLC | 470,419 | $3,470,000 | 0.80% |
| KNOTT DAVID M | 219,461 | $1,635,000 | 0.74% |
| Altium Capital Management LP | 250,000 | $1,863,000 | 0.70% |